Spondyloarthritis & psoriatic arthritis
Psoriatic Arthritis and COVID-19: Patient Perspectives in a Large Psoriatic Arthritis Cohort
Authors' conclusion
COVID-19 prevalence was low among our patients. Patients were satisfied with their care during the pandemic.
Study context
- Population
- Patients with PsA who had consented to email contact; survey June 2021–September 2021152/193 (79%) completed
- Participants
- 152 patients
- Outcome
- Prevalence of COVID-19 infection
Methodological detailsonline survey
- Online survey
Main finding
As reported in the abstract
Tested positive among 79 patients tested
4
Admitted to hospital among positives
4
Required oxygen
2
Observational data: associations, not effects.
Further findings
Patient-reported symptom severity during the pandemic, mean
- Joint
- 4.10
- Skin
- 3.24
- Overall
- 3.72
Would accept the effect of their PsA over the past month for the next few months
- Respondents
- 74%
Received at least 1 vaccine dose
- Patients
- 151 (99%)
Believed PsA medications increased COVID-19 infection risk
- Participants
- 59 (38.8%)
Happy with virtual consultations (among 130 with telemedicine assessment)
- Happy
- 83.1%
- Most were happy to continue with virtual consultations until the pandemic resolved
Average satisfaction with pandemic care (sliding 10-point scale)
- Average satisfaction
- 7.87
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →